Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-20T02:26:22.116Z Has data issue: false hasContentIssue false

10 - Therapeutic decision making in hematopoietic SCT for multiple myeloma

Published online by Cambridge University Press:  05 August 2013

By
Reinhold Munker ,
Hillard M. Lazarus  and
Kerry Atkinson
Edited by
Reinhold Munker ,
Gerhard C. Hildebrandt ,
Hillard M. Lazarus  and
Kerry Atkinson
Reinhold Munker
Affiliation:
Louisiana State University, Shreveport
Gerhard C. Hildebrandt
Affiliation:
University of Utah
Hillard M. Lazarus
Affiliation:
Ireland Cancer Center, Case Western Reserve University Hospital, Cleveland
Kerry Atkinson
Affiliation:
University of Queensland
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The BMT Data Book
Including Cellular Therapy
 , pp. 122 - 132
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Attal, M, Harousseau, JL, Facon, T, et al. 2003. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 349: 2495–2502.CrossRefGoogle ScholarPubMed
Bladé, J, Rosiňol, L, Cibeira, MT, et al. 2010. Hematopoietic stem cell transplantation for multiple myeloma beyond 2010. Blood 115: 3655–3663.CrossRefGoogle ScholarPubMed
Bruno, B, Rotta, M, Patriarca, F, et al. 2006. A comparison of allografting with autografting for newly diagnosed myeloma. N Engl J Med 356: 1110–1120.CrossRefGoogle Scholar
Bruno, B, Rotta, M, Patriarca, F, et al. 2007. A comparison of allografting with autografting for newly diagnosed myelomaN Engl J Med 356: 2434–2441.CrossRefGoogle ScholarPubMed
Durie, BGM, Harousseau, JL, Miguel, JS, et al. 2006a. International uniform response criteria for multiple myeloma. Leukemia 20: 1467–1473.CrossRefGoogle ScholarPubMed
Durie, BGM, Harousseau, JL, Miguel, JS, et al. 2006b. Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in Southwest Oncology Group chemotherapy trials. J Clin Oncol 22: 1857–1863.CrossRefGoogle Scholar
Greipp, PR, San Miguel, J, Crowley, JJ, et al. 2005. International staging system for multiple myeloma. J Clin Oncol 23: 3412–3420.CrossRefGoogle ScholarPubMed
Krishnan, A, Pasquini, MC, Logan, B, et al. 2011. Autologous haematopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial. Lancet Oncol 12: 1195–1203.CrossRefGoogle ScholarPubMed
Kristinsson, SY, Landgren, O, Dickman, PW, et al. 2007. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol 25: 1993–1999.CrossRefGoogle ScholarPubMed
Kröger, N. 2010. Unrelated stem cell transplantation for patients with multiple myeloma. Curr Opin Hematol 17: 538–543.CrossRefGoogle ScholarPubMed
Kumar, SK, Rajkumar, SV, Dispenzieri, A, et al. 2008. Improved survival in multiple myeloma and the impact of novel therapies. Blood 111: 2516–2520.CrossRefGoogle ScholarPubMed
Kumar, S. 2011. Treatment of newly diagnosed multiple myeloma in transplant-eligible patients. Curr Hematol Malig Rep 6: 104–112.CrossRefGoogle ScholarPubMed
Lokhorst, H, Einsele, H, Vesole, D, et al. 2010. International myeloma working group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma. J Clin Oncol 28: 4521–4530.CrossRefGoogle Scholar
McCarthy, PL, Owzar, K, Hofmeister, CC, et al. 2012. Lenalidomide after stem cell transplantation for multiple myeloma. N Eng J Med 366: 1770–1781.CrossRefGoogle ScholarPubMed
Moreau, P, Avet-Loiseau, H, Harousseau, JL, et al. 2011. Current trends in autologous stem cell transplantation in the era of novel therapies. J Clin Oncol 29: 1898–1906.CrossRefGoogle ScholarPubMed
Palumbo, A & Anderson, K. 2011. Multiple myeloma. N Engl J Med 364: 1046–1060.CrossRefGoogle ScholarPubMed
Palumbo, A, Falco, P, Corradini, P, et al. 2007. Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA-Italian multiple myeloma network. J Clin Oncol 25: 4459–4465.CrossRefGoogle Scholar
Pasquini, MC & Wang, Z. 2011. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides 2011/2012. Available from
Pineda-Roman, M & Tricot, G. 2007. High-dose therapy in patients with plasma cell dyscrasias and renal dysfunction. Contrib Nephrol 153: 182–194.CrossRefGoogle ScholarPubMed
Van Rhee, F, Szymonifka, J, Anaissie, E, et al. 2010. Total therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy. Blood 116: 1220–1227.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×